KRAS and TGF-β were consistently expressed throughout differentiation, whereas the expression of TP53 exhibited dynamic fluctuations—a pattern consistent with previously reported pre-tumor gene expression dynamics [22]. The gene discussed is TP53; the disease is neoplasm.